A B S T R A C T The development of antibody in response to invasive infection with type III strains of group B Streptococcus was studied in sera from 31 infants and 4 adults by means of a quantitative radioactive antigen-binding assay. Low concentrations of antibody were consistently found in the acute sera of patients who developed clinical illness. Although adults with puerperal sepsis and infants with bone or joint infection uniformly demonstrated significant rises in serum antibody concentration after recovery, much lower levels of antibody were detected in convalescent sera from infants recovering from meningitis or sepsis.
A B S T R A C T The development of antibody in response to invasive infection with type III strains of group B Streptococcus was studied in sera from 31 infants and 4 adults by means of a quantitative radioactive antigen-binding assay. Low concentrations of antibody were consistently found in the acute sera of patients who developed clinical illness. Although adults with puerperal sepsis and infants with bone or joint infection uniformly demonstrated significant rises in serum antibody concentration after recovery, much lower levels of antibody were detected in convalescent sera from infants recovering from meningitis or sepsis.
The median antibody concentration in sera from 43 parturients with type III strains of group B Streptococcus isolated from vaginal cultures whose neonates failed to develop symptomatic disease was significantly greater than that in sera from 29 mothers of infants with invasive, type III, group B streptococcal infection. Study of paired maternal and cord sera demonstrated a significant correlation between the antibody concentration in a mother's serum and that in her neonate.
INTRODUCTION
The group B Streptococcus has become an agent isolated frequently from neonates and young infants with serious infections. Among infants who have meningitis, type III strains of group B streptococci predominate (1, 2) . The apparent tropism of group B streptococcal strains possessing the capsular type III polysaccharide for the meninges of infants is unexplained (3, 4) , but chemical constituents in these bacteria do not appear to be responsible for this phenomenon. More than 70% of the cerebrospinal fluid isolates from neonates with meningitis are type III, group B streptococci or strains of Escherichia coli possessing the capsular type K1 antigen. The presence of sialic acid on the surface of these two bacteria (5, 6) has been suggested as a partial explanation for their virulence in neonates (7) . However, each of the five serotype strains of group B streptococci (la, Ib, Ic, IL, and III) contain sialic acid (8) , yet only type III strains are regularly associated with meningitis.
A disparity exists between the rate of asymptomatic colonization of neonates at birth (-92/1,000 live births) and the attack rate for symptomatic disease due to type III strains (-1.6/1,000 live births) (9, 10 [810] [811] [812] [813] [814] [815] [816] [817] [818] ganisms has been shown to be one significant variable (11) . This report describes the quantitative determination of antibody to this antigen by means of a radioactive antigen-binding assay. The antibody concentration in sera from 31 infants and 4 parturients with invasive type III, group B streptococcal infection was determined by this assay. Earlier observations that low levels of maternal antibody are related to the development of invasive, symptomatic infection among neonates and infants are quantitated and extended, and evidence is presented that this antibody is transplacentally transferred.
METHODS
Preparation of hiyperimmune antisera. New Zealand white rabbits were immunized with formalin-treated whole cell vaccines of prototype strains of group B Streptococcus (090-Ia, H36B-Ib, A909-Ic, 18RS21-II, and D136C-III) and type III strain, M732, isolated from an infant with meningitis. These methods previously have been described (6) . Sera were stored at -700C in 1 to 2-ml aliquots without preservatives until used.
Capsular antigen preparation. The polysaccharide antigen employed in both the quantitative precipitin analysis and the radioactive antigen-binding assay (RABA)' was isolated and purified from a type III strain of group B Streptococcus by methods detailed elsewhere (6) . Previous immunochemical investigation oftype-specific antigens of group B Streptococcus have established that these polysaccharides contain acid-labile determinants (6, (13) (14) (15) . It has been shown that growth of group B streptococci in standard Todd-Hewitt (Difco Laboratories, Detroit, Mich.) broth results in acid accumulation and glucose depletion during the log phase of growth (12) . For these reasons, it was deemed preferable to modify Todd-Hewitt broth to insure isolation of "intact" surface antigens. Moreover, provision of a growth medium which makes glucose available to organisms during their entire growth cycle appeared to more closely correlate with conditions which occur during human infection.
Organisms were grown in Todd-Hewitt broth modified with additional quantities of disodium phosphate and glucose (12 Farr (17) , and modified by several investigators for the detection of antibody to the capsular polysaccharides of numerous organisms, was employed (16, 18, 19) . This method has been described in detail previously (11) . Ill. (1 patient), and at New York University Medical Center, New York (1 patient). Each of these infants had type III strains of group B Streptococcus isolated from blood, cerebrospinal fluid, joint, and (or) bone cultures. Of the infants with type III, group B streptococcal infections, 9 had onset during the first 5 days of life ("early onset type") and 22 had onset between the 9th day and 7th wk of life ("late onset type"). Acute sera from babies and mothers were obtained at a mean of 3.4 days after diagnosis and convalescent sera at a mean of 23.5 days after diagnosis.
Four women with group B streptococcal puerperal sepsis were also studied; two were hospitalized at Boston City due to group B Streptococcus and well babies were compared with the Mann-Whitney U test (22) .
RESULTS
Quantitative determination of antibody by precipitation and by radioactive antigen-binding capacity.
To relate antigen-binding capacity to antibody concentration, the radioactive antigen-binding capacity of five human sera with known content of precipitating antibody was determined. The concentrations of antibody in these sera were determined by quantitative precipitation and were 8, 11, 10, 12, and 40 ug/ml.
The capacity of these sera and dilutions thereof to bind intrinsically labeled polysaccharide antigen was measured by the method of Farr (17) . A significant linear relationship was observed between percent of antigen bound and the log of the antibody concentration ( Fig. 1 Table I . The individual patient data are found in Tables II-VI. The median antibody concentrations in the acute sera of infants with sepsis, meningitis, and bone or joint infection were 0.65 ,ug/ml (range, 0.34-1.52 ,ug/ml), 0.45 ,g/ml (range, 0.32-1.52,ug/ml), and 1.05,g/ml (range, 0.334-1.75 ,ug/ml), respectively (Table I ). Low concentrations of antibody to the capsular antigen were consistently found in the acute sera ofinfants who developed clinical illness due to type III strains of group B Streptococcus. Furthermore, the acute sera from three adults with puerperal sepsis (Table I ) contained low levels of antibody to the "native" capsular antigen.
The median antibody concentration in the convalescent sera taken from four infants with sepsis or bacteremia due to type III, group B Streptococcus was 1.43 ,g/ml (range, 0.72-2.60 ,ug/ml). The mean rise in antibody concentration between paired acute and convalescent sera from infants with sepsis was 0.59 ,ug/ml which was not significant (Table I ).
The convalescent sera from 10 infants with meningitis had a median antibody concentration of0.99 ,tg/ml (range, 0.32-40.2 ,ug/ml). The mean rise in antibody concentration between the paired acute and convalescent sera in this group was 0.21 ,glml with a 95% confidence interval of 0.01-0.41 ug/ml (P < 0.05) ( Table I ). The data from one patient (S. S.) was eliminated from the calculation of mean difference because this patient had an extremely large increase in convalescent serum antibody concentration which was different from all the other observations (26-fold greater than the next highest observation). Inclusion of this value would have unduly influenced the mean difference given the small ntumber of subjects available.
The sera from five infants with osteomyelitis or septic arthritis were also studied for the development of anticapsular polysaccharide antibody. In these cases, either acute or early convalescent sera were compared to late convalescent sera. The median convalescent sertim antibody concentration was 39.2 ,ug/ml (range, 17.8-40.2 /.g/ml). The mean increase Sera from women with puerperal sepsis. Sera from four adult women with group B streptococcal puerperal sepsis were also studied ( Table I) . The median antibody concentrations in their acute and convalescent sera were 1.22 ,ug/ml (range, 0.41-1.68 Ag/ml) and 4.6 ,ug/ml (range, 3.2-5.2 ,ug/ml), respectively. The mean rise in antibody concentration between the three available acute and convalescent paired sera was 3.78 ,ug/ml with a 95% confidence interval of 3.06-4.33 ,ug/ml (P < 0.01).
Antibody prevalence in women delivering healthy and sick infants. Fig. 2 demonstrates the prevalence of antibody in sera from two groups of women: (I) 29 814 Baker, Kasper, Tager, Paredes, Alpert, McCormack, and Goroff serum of mothers whose infants had low levels of antibody was tested by studying the effect of 2-mercaptoethanol reduction on the maternal serum of patient S. T. (Table II) . Treatment with 2-mercaptoethanol led to a fall in antibody concentration from a pretreatment concentration of 12 to 1.0 ,ug/ml, indicating that the low level of antibody in this woman's infected infant resulted from failure of transplacental passage of IgM.
DISCUSSION
The polysaccharide antigen extracted from a type III strain of group B Streptococcus grown in a modified Todd-Hewitt broth may closely resemble that which the naturally infected host recognizes immunologically. This antigen is extracted by a "gentle" method and results in a more complete molecule than that extracted by methods employing heat and acid (6) . Furthermore, it is isolated from organisms grown in an optimal environment of neutral pH and sufficient glucose. It has been demonstrated that the type III polysaccharide antigen has an acid-heat labile determinant when extracted from organisms grown in a buffered Todd-Hewitt broth which is glucose limiting (6). However, organisms grown in medium with excess glucose have increased quantities of extractable capsular polysaccharide and increased cell wall thickness as determined by electron microscopy (12) . This medium more closely simulates that glucose content available in natural human infection. The capsular polysaccharide isolated from this medium is more broadly reactive serologically as indicated by its ability to precipitate with both type III-specific antiserum and antisera with group B and other type specificities (11) . Numerous attempts to immunochemically separate these two serological determinants have been unsuccessful. Further evidence that this capsular antigen represents the cell surface polysaccharide of type III, group B Streptococcus is derived from an opsonophagocytic assay with type III organisms. This capsular polysaccharide completely inhibits opsonization of homologous and heterologous type III strains by type III-specific antisera at a concentration of <1.0 ,ug/ml (23). The RABA developed by Farr is a useful method for the quantitative determination of low concentrations of antibody (17) . The quantity of antigen bound by a serum is a direct function of the concentration of antibody in that serum and the affinity of this antibody for antigen. In this investigation, the RABA was standardized by reference to antisera with known content of precipitating antibody. The degree of antigen binding was converted to antibody concentration with full recognition of the possible errors resulting from this conversion (16) . The method of least (24) . Similarly, the correlation of antibody response to polyribophosphate with age and dose has been previously documented; children under 1 yr of age have no or limited immunological response to this preparation (19) . How- ever, both polyribophosphate and purified groups A and C meningococcal polysaccharides are immunogenic in adults when given as purified vaccines or when the exposure is through natural infection (25) (26) (27) .
Those infants with meningeal invasion demonstrated significant rises in median antibody concentration upon recovery although the levels were considerably lower than those among infants of similar age with bone or joint infection. Thus, the difference between the response of infants to bacteremia alone, meningitis, and bone or joint disease may be related to differences in total antigenic stimulation as a function of exposure and (or) quantity, or to genetically determined immunocompetence. The latter has been suggested by Whisnant et al. (28) as an important factor in the immune response to H. influenzae, type b infections. If one controls for age, patients with disease manifested as meningitis have quite different serum antibody responses than do those with epiglottitis (28) .
Median concentration of antibody in groups of healthy infants, children, and women of childbearing age appears to be age dependent (29) . In a recent survey, sera were collected from 12 infants who were 2-12-mo-old, from 29 children who were 2-5-yr-old, and from 33 children who were 6-15-yr-old. The median antibody concentrations in these groups were 0.444,g/ml (0.356-0.684, range), 0.468,ug/ml (0-16.9, range), and 0.648 ,ug/ml (0-29.0, range), respectively.
A median concentration of antibody similar to that reported in these older children has been detected in the sera of 65 women age 17-35 yr (median, 0.522 ,ug/ml, range, 0.338-40.3 jig/ml). Although these median levels indicate that increasing concentration of antibody is influenced by increasing age, the range indicates that individuals with very low levels of antibody exist in any given age group (29) . 2 The absolute concentration of antibody necessary for protection against group B streptococcal disease has not been determined. The quantitation reported here appears more useful in defining the lower limits of sensitivity of this assay as well as changes in antibody concentration than the arbitrary 40% binding reported in a previous study (11) . However, the data reported for investigations of group A and group C meningococcal vaccines in infants and children given 50 ,g of group A meningococcal polysaccharide developed 9-24 gg/ml of anti-A antibody as determined by RABA, and this level was proven to be 100% protective for up to 2 yr (30). Gold et al. (31) reported that anti-A antibody concentrations of 2-4 gg/ml were induced by booster immunization in 7-and 12-mo-old infants. A recent field trial in Finland has established the efficacy of similar levels of antibody in protection against group A meningococcal disease among children 3 mo-5 yr of age (32) . Immunization of infants with 5, 25, or 100 jig of group C meningococcal vaccine has resulted in mean anti-C antibody concentrations of 0.11 ug/ml in 3-mo olds given the lowest dose, and 2.6 ,ug/ml in 12-mo olds given the highest dose (31) . These authors questioned the protective efficacy of these levels of antibody because no protection was apparent in Brazilian infants 6-23 mo of age immunized with group C meningococcal vaccine during a recent epidemic of meningitis (33).
In the present investigation, it has been demonstrated that women with low levels of antibody to capsular polysaccharide antigen isolated from type III, group B Streptococcus deliver infants who have a statistically significant increased risk for the development of clinical infection with type III strains of group B streptococci. However, prospective studies to identify the precise attack rate for disease among infants born to mothers with low levels of antibody have not been performed. It is quite likely that other host factors besides maternal antibody deficiency are related to the pathogenesis of these infections and to the unique susceptibility of infants less than 3 mo of age to disease.
Although the method employed in this investigation, a RABA, can detect antibody of all immunoglobulin classes (17, 20) , it appears that the majority of pregnant women studied in this selected population had primarily serum IgG antibody directed against capsular polysaccharide of type III, group B Streptococcus. The methods used for selection invalidate any correlation between antibody concentration and colonization status in these women. The statistically significant correlation between the antibody concentration in matched maternal-cord serum pairs was not 100% which probably relates to immunoglobulin class of antibody in some mothers. However, it seems valid to accept low concentration of antibody in maternal serum as one risk factor for the development of infant disease with type III, group B Streptococcus. Development of serologic assays specific for IgG antibody in human sera (i.e. solid-phase radioimmunoassay or enzyme-linked immunoabsorbant assay technique) would allow more precise definition of women whose offspring are at significant risk for disease.
